Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The State of the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Patients With Exudative Age-Related Macular Degeneration

NCT07375901 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.

NCT NCT07375901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07375901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The State of the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Patients With Exudative Age-Related Macular Degeneration
Lead sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Phase
Not applicable
Overall status
Completed
Start date
March 25, 2021
Completion date
April 10, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amd